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Different human TFIIIB activities direct
RNA polymerase III transcription
from TATA-containing and TATA-less
promoters
Laura Schramm,1,2 P. Shannon Pendergrast,2 Yuling Sun,2,3 and Nouria Hernandez2–4
1Department of Pharmacology, State University of New York at Stony Brook, Stony Brook, New York 11794, USA; 2Cold
Spring Harbor Laboratory and 3Howard Hughes Medical Institute, Cold Spring Harbor, New York 11724, USA
Transcription initiation at RNA polymerase III promoters requires transcription factor IIIB (TFIIIB), an
activity that binds to RNA polymerase III promoters, generally through protein–protein contacts with DNA
binding factors, and directly recruits RNA polymerase III. Saccharomyces cerevisiae TFIIIB is a complex of
three subunits, TBP, the TFIIB-related factor BRF, and the more loosely associated polypeptide . Although
human homologs for two of the TFIIIB subunits, the TATA box–binding protein TBP and the TFIIB-related
factor BRF, have been characterized, a human homolog of yeast B has not been described. Moreover, human
BRF, unlike yeast BRF, is not universally required for RNA polymerase III transcription. In particular, it is not
involved in transcription from the small nuclear RNA (snRNA)–type, TATA-containing, RNA polymerase III
promoters. Here, we characterize two novel activities, a human homolog of yeast B, which is required for
transcription of both TATA-less and snRNA-type RNA polymerase III promoters, and a factor equally related
to human BRF and TFIIB, designated BRFU, which is specifically required for transcription of snRNA-type
RNA polymerase III promoters. Together, these results contribute to the definition of the basal RNA
polymerase III transcription machinery and show that two types of TFIIIB activities, with specificities for
different classes of RNA polymerase III promoters, have evolved in human cells.
[Key Words: human TFIII; human B; BRFU; U6 snRNA gene; RNA polymerase III]
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Correct initiation of transcription by RNA polymerase
III requires a number of factors. Of particular interest is
the transcription factor IIIB (TFIIIB), because TFIIIB di-
rectly contacts RNA polymerase III, and in yeast, once
recruited to the promoter, TFIIIB is sufficient to support
several rounds of RNA polymerase III transcription (re-
viewed in Paule and White 2000). Yeast TFIIIB is well
defined and consists of three subunits, the TATA box–
binding protein TBP (Kassavetis et al. 1992), the TFIIB-
related factor BRF (TDS4/PCF4) (Buratowski and Zhou
1992; Colbert and Hahn 1992; Lo´pez-De-Leo´n et al.
1992), and the B protein (TFIIIB90/TFC5/TFC7) (Kassa-
vetis et al. 1995; Roberts et al. 1996; Ru¨th et al. 1996). In
various RNA polymerase III promoters, the mode of
TFIIIB recruitment varies. In the gene-internal 5S and
transfer RNA (tRNA) promoters, the promoter elements
are first recognized by TFIIIA and TFIIIC or directly by
TFIIIC, respectively, and this allows the subsequent re-
cruitment of TFIIIB (reviewed in Paule and White 2000).
On the yeast U6 promoter, which contains a TATA box
∼25 nucleotides upstream of the transcription start site,
TFIIIB is also recruited in a TFIIIC-dependent manner
(Brow and Guthrie 1990; Burnol et al. 1993; Eschenlauer
et al. 1993), but on naked DNA templates in vitro, it can
be recruited by direct binding of the TBP subunit to the
TATA box (Moenne et al. 1990; Margottin et al. 1991). In
all these cases, however, the same TFIIIB complex, con-
taining the same three subunits, is used (Joazeiro et al.
1994).
In mammalian cells, the situation appears more com-
plicated. Like yeast TFIIIB, mammalian TFIIIB contains
TBP (Lobo et al. 1992; Taggart et al. 1992; White and
Jackson 1992) and a homolog of yeast BRF, human BRF
(hBRF) (Mital et al. 1996), also called TFIIIB90 (Wang and
Roeder 1995). These two subunits associate strongly
with each other (Wang and Roeder 1995; Mital et al.
1996). A homolog of yeast B has not been identified in
mammals or any other organism. In addition, unlike in
yeast, there appear to be variants of the TFIIIB complex.
In particular, the human U6 promoter, which exempli-
fies a class of RNA polymerase III promoters whose es-
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sential elements are all located within the 5 flanking
sequence of the gene, appears to use another form of
TFIIIB than the tRNA-type Ad2 VAI promoter (Lobo et
al. 1992; Teichmann and Seifart 1995; Mital et al. 1996;
Henry et al. 1998a), which contains a gene-internal pro-
moter. The core U6 promoter, which is sufficient to di-
rect basal levels of transcription in vitro, consists of a
proximal sequence element (PSE) centered around posi-
tion −56 relative to the start site and a TATA box cen-
tered around position −27. The U6 promoter is highly
similar to the RNA polymerase II small nuclear RNA
(snRNA) core promoters, which consist of only the PSE
(see Henry et al. 1998a and references therein). The PSE
recruits a multisubunit complex called SNAPc (Henry et
al. 1995, 1998b) or PTF (Yoon et al. 1995), and the U6
TATA box recruits TBP (Lobo et al. 1991; Simmen et al.
1991). It is not clear which other TFIIIB components
aside from TBP are involved in U6 transcription.
Wang and Roeder (1995) showed that depletion of ex-
tracts with anti-hBRF antibodies debilitated U6 tran-
scription, but addition of recombinant hBRF did not re-
store activity. They concluded that hBRF was required
for U6 transcription but as part of a complex that some-
how differed from the TFIIIB complex required for VAI
transcription. On the other hand, we showed that deple-
tion of extracts with antibodies directed against the C-
terminal half of hBRF debilitated transcription from the
VAI promoter but not from the U6 promoter. Because
the antibody treatment removed >95% of the endog-
enous hBRF present in extracts, the results suggest that
hBRF is in fact not required for U6 transcription (Mital et
al. 1996). Indeed, we were able also show that upon
depletion of extracts with anti-TBP and anti-hBRF anti-
bodies, VAI transcription was only restored by addition
of a combination of both TBP and hBRF, whereas U6
transcription could be restored by addition of only re-
combinant TBP. In fact, U6 transcription was dimin-
ished by addition of hBRF (Henry et al. 1998a).
Thus, two main questions remain concerning mam-
malian TFIIIB. First, it is currently unclear whether a
mammalian homolog of yeast B exists, and whether it
is required for RNA polymerase III transcription of genes
with internal promoters, such as the VAI gene, and genes
with external promoters that recruit SNAPc, such as the
human U6 gene. Second, the apparent lack of require-
ment for hBRF in U6 transcription raises the possibility
that the mammalian snRNA-type RNA polymerase III
promoters use a factor different from, but related to,
hBRF. Here, we report the characterization of two new
transcription factors, human B (hB) and a BRF-related
factor we refer to as hBRFU. hB is required for tran-
scription of both the VAI and the U6 genes. hBRFU is a
protein with an N-terminal domain related to both hBRF
and TFIIB, and a divergent C-terminal domain. The pro-
tein is required for U6 but not VAI transcription. These
results show that there are two forms of the basal RNA
polymerase III transcription factor IIIB in mammalian
cells. They also identify the first transcription factors
uniquely required for transcription of RNA polymerase
III but not RNA polymerase II—snRNA promoters. To-
gether with our previous results indicating that TFIIB is
required for transcription of the human RNA polymerase
II snRNA genes (Kuhlman et al. 1999), these results sug-
gest that the key event in the determination of RNA
polymerase specificity in the human snRNA promoters
is the recruitment of hBRFU versus TFIIB.
Results
Characterization of a human homolog of S. cerevisiae B
Both the TBP and BRF subunits of yeast TFIIIB have hu-
man homologs, suggesting that a human homolog of
yeast B exists. S. cerevisiae B contains a SANT do-
main. The SANT domain is related to a Myb repeat and
was originally identified in a number of proteins, includ-
ing the SWI3, ADA2, N-Cor, and yeast TFIIIB B pro-
teins (Aasland et al. 1996). In yeast B, C-terminal dele-
tions of B that lack most of the SANT domain are in-
active for in vitro transcription of a TATA-less tRNA
gene, although they are still active for transcription of
the TATA-containing U6 snRNA gene (Kumar et al.
1997). We used the S. cerevisiae sequence as a query to
search the human and mouse expressed sequence tag
(EST) databases and originally identified a short mouse
sequence (GenBank accession number AA200560) en-
coding 21 amino acids with strong similarity to part of
the yeast B SANT domain. We used this short sequence
to design primers, and through successive polymerase
chain reactions (PCR) with various libraries and cDNA
prepared from HeLa-cell total RNA as well as through
database searches, we assembled a sequence encoding a
protein with a calculated molecular mass of 156.129 kD,
shown in Figure 1A. We also obtained two variations in
this sequence. In the first, nucleotides 414–578 (see Gen-
Bank accession number AF298151 for the nucleotide
numbering), encoding amino acids 109–163, are missing
(indicated by vertical brackets in Fig. 1A). Because the
nucleotide sequence extending from nucleotides 414 to
578 starts with a GT and ends with an AG, the shorter
sequence most probably corresponds to a splicing vari-
ant. In the second variation, an additional T residue is
inserted at position 4192 (GenBank accession number
AF298152). As a result, the last 21 amino acids of the
protein in Figure 1A (SEEINNSMIILSLSPTTLKNL) are
replaced by the shorter sequence FRGNK. The two se-
quences may correspond to different alleles. As detailed
in Materials and Methods, several recent entries in the
database can be aligned with part or most of the se-
quence shown in Figure 1A.
When the protein sequence shown in Figure 1A is used
as the query to search the Swiss-Prot database, the best
match identified is the S. cerevisiae B protein. As de-
tailed below, several other pieces of evidence suggest
that this protein is indeed a functional human homolog
of yeast B, and we therefore refer to it as hB.
Figure 1B shows the regions of similarity with yeast
B (ScB). hB contains a region that is 43% identical
with the yeast B SANT domain (black box). In addition,
Two forms of human TFIIIB
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Figure 1. (See facing page for legend.)
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hB shows 21% identity over a 131–amino acid (aa) re-
gion upstream, and 17% identity over a 115-aa region
downstream, of the SANT domain (hatched boxes).
Figure 1C shows an alignment including a 58-aa region
directly upstream of the SANT domain and the SANT
domain itself of hB, ScB, as well as putative B ho-
mologs from various organisms (see the legend to Fig.
1C). In all of these sequences, the SANT domain is re-
markably conserved, and the mouse and human se-
quences are identical over this region. The resulting con-
sensus for B SANT domains differs from the SANT
domain consensus (Aasland et al. 1996) at several posi-
tions, marked by arrowheads in Figure 1C. In addition,
the B SANT sequences show absolute conservation of
eleven amino acids (indicated in boldface), most of
which are not absolutely conserved in all SANT do-
mains. Thus, B SANT domains form a subfamily of
SANT domains. The 58-aa region upstream of the SANT
domain is also shown, because in ScB, small deletions
in this region severely debilitate transcription from lin-
ear (but not supercoiled) templates in vitro (Kassavetis et
al. 1998). Although this region is less conserved, it shows
clusters of conserved amino acids, especially around the
invariant glycine. Thus, this region may perform a simi-
lar function in all B homologs.
Starting at amino acid 822, human B consists of a
series of nine long repeats of 53–55 amino acids, each of
which can be further divided into two shorter but more
degenerate repeats of 26–28 amino acids, followed by one
additional short repeat. In a BLAST search of the Swiss-
Prot database, regions of hB comprising the repeats and
extending as far as upstream of the SANT domain align
with proteins belonging to the myosin and intermediate
filament families and characterized by long, -helical do-
mains that can form coiled-coil structures. However,
programs that predict coiled-coil regions such as COIL
(Lupas et al. 1991) or PAIRCOIL (Berger et al. 1995), and
that give very high scores to the proteins that align with
hB, do not predict similar extended rod-like structures
in hB, although hB does show short regions with high
scores. Thus, the significance of these similarities is not
clear. Each of the 19 short repeats contains serine and
threonine residues (indicated in boldface in Fig. 1D) that
are potential phosphorylation sites for various kinases,
including PKC, PKA, CAMII, CDC2, and CKII kinases,
suggesting that this part of the molecule may have a
regulatory function. This very striking repeated se-
quence is not present in the yeast protein.
To determine whether the protein shown in Figure 1A
corresponds to an endogenous protein, we raised anti-
bodies against several peptides derived from the amino
acid sequence shown in Figure 1A (see Materials and
Methods). We then performed an immunoblot of the fol-
lowing: hB translated in vitro in a rabbit reticulocyte
lysates; whole-cell extract (WCE); a mixture of in vitro–
translated hB and whole-cell extract; and unpro-
grammed reticulocyte lysate (control). As shown in Fig-
ure 2, the anti-hB antibody recognized a prominent
polypeptide of ∼160 kD in HeLa-cell extracts (lane 3),
which comigrated with in vitro–translated hB (lanes 1
and 2). Another polypeptide of ∼250 kD that is promi-
nently detected in the HeLa-cell extract (lane 3) may
correspond to a cross-reacting protein or, perhaps, a hy-
perphosphorylated form of hB. No major signal was ob-
tained in the unprogrammed lysate control lane (lane 4).
Thus, cells contain a protein that is recognized by anti-
hB antibodies and that comigrates with recombinant
hB (rhB).
Figure 1. Structure of a hB. (A) Predicted hB protein sequence (GenBank accession number AF298151). The SANT domain is
indicated by a large horizontal bracket above the sequence. The repeated sequences are indicated by arrows. The sequence between the
vertical brackets (amino acids 109–163) is lacking in some cDNAs that probably correspond to splicing variants. (B) Regions of
similarity in the Homo sapiens and S. cerevisiae B sequences (HsB and ScB, respectively). The black boxes correspond to the SANT
domain; the hatched boxes indicate regions of lower but still significant similarity on either side of the SANT domain. The percentages
indicate identities between the two proteins in the regions delimited by the dotted lines. The numbers above the boxes indicate aa
numbering. The small arrows indicate the repeats in hB. (C) Alignment of the SANT domain and region immediately upstream from
hB (Hs) and ScB (Sc), as well as putative mouse (Mm), Drosophila melanogaster (Dm), Caenorhabditis elegans (Ce), Schizosaccha-
romyces pombe (Sp), and Arabidopsis thaliana (At) B homologs. The SANT domain is indicated by the horizontal bracket above the
sequence. The region N-terminal of the SANT domain was shown, in ScB, to be required for efficient transcription of linear yeast U6
templates in vitro (Kassavetis et al. 1998). The amino acids in boldface are identical in all sequences. The amino acids indicated in the
consensus are identical in at least four of the seven sequences. (+) similar amino acids in all sequences; (*) similar amino acids in at
least five of the seven sequences. The following amino acids were considered similar: V, I, L, and M; D and E; N and Q; R, K, and H;
S and T; and W, F, and Y. The SANT consensus sequence (Aasland et al. 1996) is also shown. In the SANT consensus: (%) semicon-
served hydrophobicity; (#) strongly conserved hydrophobicity; (a) conserved acidic residues; and (b) conserved basic residues. The
positions marked with arrowheads indicate positions not conserved in the B and SANT consensus sequences. The GenBank accession
numbers are as follows: Mm ESTs, AI315861, AI315862, and AI787462; Ce genomic sequences U97016 (B0261) (nucleotides 25059–
25185 and 25518–25780); Dm protein, AAF53291.1 (CG9305 gene product); Sp protein, T41239; and At protein T08564 (hypothetical
protein T22F8.60). The numberings correspond to the sequence shown in (A) for HsB, to the sequences published (Kassavetis et al.
1995; Roberts et al. 1996; Ru¨th et al. 1996) for ScB, and to the sequences corresponding to the protein accession numbers indicated
for other sequences. For the Mm sequence, the numbering corresponds to a putative mouse B N-terminal region (amino acids 1–377)
assembled from an alignment of various ESTs (GenBank accession numbers AI527964, AI317698, AI787358, AI526613, AI316225,
AI639984, AA168265, AW456745, AW049390, AI429656, AI430369, AI450927, W91010, AI787462, AI315861, AI315862, AI892036,
and AI315863), and for the Ce sequence, the numbering is arbitrary. (D) Alignment of the repeats within the C-terminal half of hB.
As indicated by the arrows, each repeat can itself be subdivided into two short imperfect repeats. Residues in boldface indicate
potential phosphorylation sites for various kinases, including PKC, PKA, CAMII, and CKII kinases.
Two forms of human TFIIIB
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hB is required for transcription from both the VAI
and the U6 promoters
To determine whether hB plays any role in transcrip-
tion by RNA polymerase III, we covalently attached anti-
hB antibodies to beads and used these beads to deplete
extracts of endogenous hB. The extracts were then
tested for their ability to support transcription from four
types of promoters: the Ad2 VAI gene–internal RNA
polymerase III promoter, the RNA polymerase III U6 and
RNA polymerase II U1 snRNA promoters, and the Ad2
major late (Ad2 ML) promoter, a typical mRNA-type
RNA polymerase II promoter. The results are shown in
Figure 3. In all cases, treatment of the extracts with pre-
immune antibody beads had little effect on transcription
(cf. lane 10 with lanes 1 and 5). In contrast, treatment of
the extracts with anti-B antibodies directed against two
different peptides (antibodies 913 and 843) severely de-
bilitated transcription from both the VAI and U6 RNA
polymerase III promoters but had little effect on tran-
scription from the RNA polymerase II U1 and Ad2 ML
promoters (cf. lane 2 with lane 1, and lane 6 with lane 5).
The effect was specific, because incubation of each an-
tibody with the peptide against which it was raised, but
not with a nonspecific peptide, abolished the inhibitory
effect (lanes 3, 4, 7, and 8). As a control, we also treated
the extracts with an antibody directed against the
SNAP43 subunit of SNAPc (Henry et al. 1995). We have
shown before that SNAPc is specifically required for
transcription from both RNA polymerase II and III sn-
RNA promoters (Sadowski et al. 1993; Henry et al.
1998b). As expected, treatment with the anti-SNAP43
antibody debilitated RNA polymerase III transcription
from the U6 snRNA but not the Ad2 VAI promoter, and
RNA polymerase II transcription from the U1 snRNA
but not the Ad2 ML promoter (lane 9). Note that in the
U1 panel, the lower band (U1) corresponds to correctly
initiated U1 RNA; the upper band (5’ RT) corresponds to
a read-through RNA initiating at cryptic promoters
within vector sequence (Sadowski et al. 1993).
To ensure that the debilitating effect on VAI and U6
transcription observed above upon treatment of tran-
scription extracts with anti-hB antibodies resulted
from depletion of hB, we tested whether rhB could
reconstitute transcription in the depleted extracts. As
shown in Figure 4, addition of increasing amounts of
recombinant hB (rhB) produced in Escherichia coli to
Figure 3. Depletion of hB debilitates RNA polymerase III, but
not RNA polymerase II, transcription in vitro. Whole-cell ex-
tract was treated with beads coated with either the preimmune
antibodies (lanes 1 and 5) or the anti-B antibodies (lanes 2–4
and 6–8) indicated above the lanes (913 is hB-2; 843 is hB-
3). In lanes 3 and 7, and in lanes 4 and 8, the antibody beads were
preincubated either with the specific peptide against which the
antibodies were raised or with nonspecific peptide, as indicated.
In lane 9, the extract was treated with beads coated with an
antibody directed against the SNAP43 subunit of SNAPc. Ali-
quots of the variously treated extracts were then tested in par-
allel for their ability to direct transcription from the Ad2 VAI,
human U6, human U1, and Ad2 major late (AdML) promoters.
The bands corresponding to correctly initiated RNA are indi-
cated in each panel. In the U1 panel, the band labeled 5 RT
corresponds to RNA initiated within the vector and reading
through the U1 snRNA promoter (Sadowski et al. 1993). Lane 10
shows transcription in untreated whole-cell extract.
Figure 2. rhB comigrates with endogenous B from HeLa
cells. The immunoblot was performed with an anti-hB anti-
body (hB-2, CS913). (Lane 1) 5 µL of hB translated in vitro;
(lane 2) 5 µL of hB translated in vitro and 2.5 µL of whole
HeLa-cell extract (WCE); (lane 3) 2.5 µL of HeLa-cell extract; and
(lane 4) 5 µL of unprogrammed rabbit reticulocyte lysates (con-
trol). The position of hB and the positions of molecular weight
markers are indicated.
Schramm et al.
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depleted extracts restored both VAI (Fig. 4A) and U6 (Fig.
4B) transcription to levels higher than, or comparable to,
those observed in the starting extract (cf. lanes 3–5 with
lanes 1, 2, and 6 in Fig. 4A, and lanes 3 and 4 with lanes
1, 2, and 5 in Fig. 4B; note that in Fig. 4B, lane 5 was
overloaded as evidenced by the intensity of the internal
control signal [IC]). These results indicate that hB is an
RNA polymerase III transcription factor that, unlike
hBRF (Mital et al. 1996), is required for transcription
from both TATA-less and TATA-containing promoters.
hB is found on the U6 promoter region in vivo
These experiments strongly suggest that hB functions
in transcription of the human U6 gene. To determine
whether hB can be found in the human U6 promoter
region in vivo, we used the chromatin immunoprecipi-
tation assay, in which intact cells are first treated with
formaldehyde to cross-link proteins to DNA and then
chromatin is extracted, extensively sonicated, and used
as starting material for immunoprecipitations, with an-
tibodies directed against the protein of interest (see Boyd
et al. 1998; Kuo and Allis 1999; and references therein).
The presence of specific DNA sequences in the immu-
noprecipitates can then be ascertained by PCR. We per-
formed immunoprecipitations of cross-linked chromatin
with anti-hB and, as a control, preimmune antibodies
and anti-TFIIB antibodies (Kuhlman et al. 1999). We then
checked the immunoprecipitates for the presence of U6
and, as a control, U1, promoter sequences.
The organization of the human U6 genes is not well
understood, but U6 genes and pseudogenes appear dis-
persed in the genome. A BLAST search with the U6 gene
we work with (Kunkel et al. 1986) indicated that the
promoter region is probably unique; we therefore de-
signed a pair of test primers within the U6 promoter. The
control primers hybridized to a region 4 kb upstream of
the U6 transcription start site. The U1 snRNA genes
number an estimated 30–100 copies per haploid genome,
each carried on a tandemly repeated 45-kb fragment
(Bernstein et al. 1985). In addition, the human genome
contains a large number of U1 pseudogenes. Most have
different flanking sequences than the true genes, but the
U1 class I pseudogenes have 5 and 3 flanking regions
very similar to those of the true genes (Denison and
Weiner 1982). We designed test primers capable of hy-
bridizing to the true U1 promoters but not to flanking
regions of U1 pseudogenes. The control primers hybrid-
ized to a region within the 45-kb repeat (but not in re-
peated sequences such as Alu sequences) at 7 kb up-
stream of the U1 start site, to ensure that any difference
in signal between test and control primers did not result
from a difference in copy number of the target DNA
sequence. For both the U6 and the U1 control primers,
the size of the expected fragment is close to that ex-
pected from the test primers, to ensure comparable PCR
efficiency.
As shown in Figure 5, both the test and control prim-
ers gave the expected fragments when used to amplify
the starting material for immunoprecipitation (lanes
9–12). As expected, no fragments were obtained with ma-
terial precipitated by preimmune antibodies or in the
Figure 4. hB is required for RNA polymerase III transcription
from the Ad2 VAI and human U6 promoters. (A) Whole-cell
extract was treated with beads coated with either preimmune
(lane 1) or anti-hB (lanes 2–5) antibodies and tested for tran-
scription from the Ad2 VAI promoter. In lanes 3–5, increasing
amounts of rhB (rhB) expressed in E. coli were added to the
depleted extract. Lane 6 shows VAI transcription in untreated
whole-cell extract. (B) Whole-cell extract treated with beads
coated with the preimmune (lane 1) or anti-hB (lanes 2–4) an-
tibodies and tested for U6 transcription. In lanes 3 and 4, in-
creasing amounts of rhB expressed in E. coli were added to the
depleted extract. Lane 5 shows U6 transcription in untreated
whole-cell extract. (IC) internal control signal.
Figure 5. hB is found in the U6 promoter region in vivo.
Rapidly growing HeLa cells were treated with formaldehyde;
then cross-linked chromatin was extracted, sonicated, and used
as starting material for immunoprecipitations with beads
coated with either preimmune (lanes 1 and 2), anti-hB (lanes 3
and 4), or anti-TFIIB (lanes 5 and 6) antibodies, or just beads
alone (lanes 7 and 8). The immunoprecipitated material was
then analyzed by PCR with test (T) primers specific for the U6
(upper panel) or U1 (lower panel) promoters, or control (C) prim-
ers hybridizing to a unique region located 4 kb upstream of the
human U6 snRNA gene (upper panel) or a unique region within
the 45-kb U1 repeat (Bernstein et al. 1985) 7 kb upstream of the
U1 gene (see Materials and Methods for details). Lanes 9–12
show PCRs performed with the test (T) or control (C) primers
with 0.04% and 0.02% of the input material used for immuno-
precipitation, as indicated above the lanes.
Two forms of human TFIIIB
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absence of antibodies (lanes 1, 2, 7, and 8). However, the
material immunoprecipitated by anti-B antibodies con-
tained U6 promoter sequences but not sequences located
4 kb upstream of the U6 transcription start site. U1 pro-
moter sequences were not present above the background
obtained with the test primers in this immunoprecipi-
tation. In sharp contrast, U1, but not U6, promoter
sequences were present at levels well above the back-
ground in material immunoprecipitated with an anti-
TFIIB antibody, consistent with our previous observa-
tions that TFIIB is required for RNA polymerase II but
not RNA polymerase III transcription from snRNA pro-
moters (Kuhlman et al. 1999). Together, these data
strongly argue that hB is indeed part of the U6 initia-
tion complex.
Isolation of a cDNA encoding a factor related to both
hBRF and TFIIB
We recently generated antibodies directed against vari-
ous peptides within the TFIIB-related N-terminal do-
main of hBRF and observed that depletion of extracts
with one of these antibodies (1043), unlike depletion
with all other anti-hBRF antibodies we have tested, de-
bilitated U6 transcription (see below). This result was
similar to the results obtained by Wang and Roeder
(1995) and suggested that a protein different from, but
related to hBRF was required for U6 transcription. We
therefore, searched the database for human proteins with
similarity to the N-terminal domain of hBRF. The high-
est scoring hit after TFIIB was an unnamed protein with
a calculated molecular mass of 46.42 kD (GenBank ac-
cession number BAA91975). We used the corresponding
DNA sequence to design primers and amplify by PCR a
sequence from total HeLa-cell cDNA, which can code for
the protein shown in Figure 6A (GenBank accession
number AF298153). This protein is identical to that en-
coded by the BAA91975 entry except that a cysteine at
position 157 in BAA91975 is replaced by a tyrosine in
our sequence.
Figure 6B shows a schematic comparison of this pro-
tein, which we call hBRFU, with the TFIIB homolog
from Archaea Pyrococus furiosus (PfTFIIB), human TFIIB
(hTFIIB), and hBRF; Figure 6C shows the corresponding
alignment. hBRFU is strikingly similar to all three pro-
teins. In the region bracketed by a dotted line in Figure
6B, it is 21.2%, 20.1%, and 18.1% identical with PfTFIIB,
hTFIIB, and hBRF, respectively. This region of conserva-
tion contains two structured domains, a zinc ribbon (in-
dicated in blue), whose structure was solved by nuclear
magnetic resonance (NMR) in PfTFIIB (Zhu et al. 1996)
and modeled in yeast TFIIB and BRF (Hahn and Roberts
2000), and a core (indicated in purple) whose structure
was solved in human TFIIB by NMR and crystallography
(Bagby et al. 1995; Nikolov et al. 1995). Strikingly, the
regions in which the hBRFU sequence is most similar to
the three other proteins are precisely within these struc-
tured regions. Within the zinc ribbon domain, hBRFU
is 40.6%, 37.5%, and 31.2% identical with PfTFIIB,
hTFIIB, and hBRF, respectively, strongly suggesting that
this region of BRFU also adopts a zinc ribbon structure.
Within the core domain up to amino acid 259 in hBRFU
(the C-terminal end of the core is not conserved), the
percentage of identities varies between 18.7% and
19.8%. The hTFIIB core domain consists of two struc-
tural repeats (indicated by arrows in Fig. 6B and by ar-
rows above the sequence in Fig. 6C) (Nikolov et al. 1995),
which correspond to repeats in the sequence. In hBRF,
the sequence repeats are less similar to each other than
are those in TFIIB, and in BRFU, the second repeat con-
tains an insertion relative to the first repeat and the re-
peats are altogether barely recognizable. Nevertheless,
the strong similarities in the sequence suggest that the
core of BRFU adopts a structure similar to the core of
hTFIIB.
To determine whether cells indeed contain a protein
corresponding to hBRFU, we fractionated on an SDS–
polyacrylamide gel purified recombinant hBRFU
(rhBRFU) expressed in E. coli, a P11 B fraction from
HeLa-cell extracts, and a mixture of both. The proteins
were transferred to nitrocellulose and probed with the
antibody capable of debilitating U6 transcription in vitro
(antibody 1043). As shown in Figure 7, the antibody rec-
ognized rhBRFU as well as a comigrating HeLa-cell pro-
tein. Thus, the protein we identified in the database is
indeed recognized by the 1043 antibody and is probably
expressed in HeLa cells.
hBRFU functions for U6 but not VAI transcription
in vitro
To determine whether hBRFU might be involved in
RNA polymerase III transcription from the human U6
promoter, we treated extracts with the 1043 antibodies
directed against the N-terminal domain of hBRF. As
shown in Figure 8, this treatment resulted in debilitation
of transcription from both the U6 (Fig. 8A) and the VAI
(Fig. 8B) promoters (cf. lanes 2 and 3 in Fig. 8A, and lanes
1 and 2 in Fig. 8B). We then complemented the extracts
with rhBRFU expressed in E. coli. Strikingly, transcrip-
tion from the U6 promoter, but not the VAI promoter,
was restored to levels comparable to those obtained in
extracts depleted with preimmune antibody beads or un-
treated extract (cf. lanes 4 and 5 with lanes 1 and 2 in Fig.
8A and lanes 3–5 with lanes 1 and 6 in Fig. 8B). VAI
transcription could be reconstituted by addition of hBRF
(lanes 8 and 9 in Fig. 8B) but U6 transcription could not
be (not shown), which is consistent with our previous
observations (Mital et al. 1996; Henry et al. 1998a). Thus,
human cells contain at least two homologs of yeast BRF,
each specific for different types of RNA polymerase III
promoters.
Discussion
Unlike the TFIIIB activity in yeast cells, which has been
well defined and is apparently unique, the TFIIIB activity
in other organisms has not been completely defined.
Here, we have characterized a human homolog of yeast
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Figure 6. Structure of hBRFU. (A) Predicted hBRFU protein sequence (GenBank accession number AF298153). (B) Regions of simi-
larities in the Pyrococcus furiosus TFIIB homolog (PfTFIIB) and the hTFIIB, hBRF, and hBRFU sequences. The location of the
structured zinc ribbon as determined in PfTFIIB by nuclear magnetic resonance (Zhu et al. 1996), and as modeled in BRF and TFIIB
(Hahn and Roberts 2000), and the location of the corresponding region in hBRFU are indicated in blue. The location of the structured
core domain of TFIIB (Bagby et al. 1995; Nikolov et al. 1995) and that of the corresponding regions in the other proteins are indicated
in purple. The region conserved between the proteins is indicated by the vertical stripped lines. The percentages below the sequences
indicate percentage of identity between hBRFU and PfTFIIB, hTFIIB, or hBRF within the region bracketed by the vertical stripped lines
as calculated from the alignment shown in C. (C) Alignment of PfTFIIB, hTFIIB, and the N-terminal regions of hBRF and hBRFU. The
alignment was performed with the ClustalW program and the default parameters. The amino acids in boldface are identical in all
sequences. The amino acids indicated in the consensus are identical in three of the four sequences. (+) similar amino acids in all
sequences; (*) similar amino acids in three of the four sequences. The following amino acids were considered similar: V, I, L, and M;
D and E; N and Q; R, K, and H; S and T; and W, F, and Y. The horizontal arrows above the sequences indicate the location of the
structural repeats (Nikolov et al. 1995). The location of the structured zinc ribbon is indicated in blue, and that of the core (hTFIIB
amino acids 113–316) in purple.
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B, and we have shown that this protein is required for
transcription of both TATA-less, tRNA-type promoters
and TATA-containing, snRNA-type RNA polymerase III
promoters. In addition, we have identified a factor re-
lated to both BRF and TFIIB, which is specifically re-
quired for transcription from the U6 snRNA-type pro-
moter. These results characterize TFIIIB, the central
RNA polymerase III transcription factor, in human cells.
Identification of a functional human homolog
of yeast B
hB is a functional homolog of yeast B by several crite-
ria. First, a BLAST search of the protein database with
hB as the query returns yeast B as the highest scoring
match; second, hB is functional for RNA polymerase III
transcription from both the VAI and the U6 promoters in
vitro; and third, it can be localized to the U6 promoter in
vivo. We have shown in Figure 1C putative B homologs
from a number of species, including Mus musculus, D.
melanogaster, C. elegans, S. pombe, and A. thaliana.
Although there are no functional data concerning these
proteins, the observations that (1) they show sequence
conservation upstream of the SANT domain, in a region
known to be functionally important in yeast B (Kumar
et al. 1997), and that (2) their SANT domains are more
similar to each other than to SANT domains from other
proteins, suggest that they indeed correspond to func-
tional B proteins.
The C-terminal region of hB consists of 19 repeats of
26–28 amino acids, each of which contains a number of
potential serine and threonine phosphorylation sites.
This is reminiscent of the C-terminal domain of the larg-
est subunit of RNA polymerase II, which for human
RNA polymerase II consists of 52 heptad repeats with
serine, threonine, and tyrosine phosphorylation sites. In
the case of the largest RNA polymerase II subunit, the
C-terminal domain is involved in a number of functions,
including release of the transcription complex from the
promoter (promoter clearance), recruitment of mRNA
processing factors, and perhaps inactivation of transcrip-
tion at mitosis (see Orphanides et al. 1996; Parsons and
Spencer 1997; McCracken et al. 1998; and references
therein). RNA polymerases III and I do not contain do-
mains similar to the RNA polymerase II CTD, and the
RNA polymerase III initiation complex, unlike the RNA
polymerase II initiation complex, is not known to con-
tain any kinase activity. The hB C terminus may, how-
ever, be involved in regulatory functions. For example,
inactivation of RNA polymerase III transcription at mi-
tosis is known to occur through inactivation of TFIIIB,
but the TFIIIB components affected have not been de-
fined (Gottesfeld et al. 1994; White et al. 1995; Leresche
et al. 1996). Perhaps this inactivation involves phos-
phorylation of the repetitive C-terminal domain of hB.
Moreover, TFIIIB activity is regulated during interphase
and has been shown to associate with the retinoblastoma
protein (Rb) and the p107 and p130 pocket proteins, as
well as with p53, all of which can downregulate RNA
polymerase III transcription (Larminie et al. 1997; Cairns
and White 1998; Sutcliffe et al. 1999). Perhaps some of
these proteins associate with hB, and the association
may be regulated in part by phosphorylation of the hB
C-terminal domain.
Identification of hBRFU
The generation of the anti-peptide antibody 1043, which
is capable of debilitating U6 transcription when used to
deplete transcription extracts, allowed us to identify
Figure 7. hBRFU is expressed in HeLa cells. The immunoblot
was performed with an anti-hBRFU/hBRF antibody (CS1043).
(Lane 1) rhBRFU expressed in E. coli; (lane 2) rhBRFU expressed
in E. coli and 2 µL of P11 B fraction; and (lane 3) 2 µL of P11 B
fraction. rhBRFU migrates as a protein of ∼50 kD. The addi-
tional bands seen in the P11 fraction probably correspond to
cross-reacting proteins.
Figure 8. hBRFU is specifically required for U6 transcription.
(A) A whole-cell extract was treated with beads coated with
preimmune (lane 2) or CS1043 (lanes 3–5) antibodies and tested
for transcription from the U6 promoter. In lanes 4 and 5, in-
creasing amounts of rhBRFU were added to the depleted extract.
Lane 1 shows U6 transcription in untreated whole-cell extract.
(B) A whole-cell extract was treated with beads coated with
preimmune (lane 1) or CS1043 (lanes 2–5 and 7–9) antibodies
and tested for transcription from the VAI promoter. In lanes 3–5,
increasing amounts of rhBRFU were added to the depleted ex-
tract. In lanes 8 and 9, increasing amounts of rhBRF were added
to the depleted extract. Lane 6 shows U6 transcription in un-
treated whole-cell extract.
Schramm et al.
2658 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on January 31, 2014 - Published by genesdev.cshlp.orgDownloaded from 
hBRFU. The N-terminal domain of hBRFU is related to
the N-terminal domains of both TFIIB and BRF, and thus
hBRFU is a new member of the TFIIB family of proteins,
which includes TFIIB and BRF of various species. Very
strikingly, unlike TFIIB and hBRF, which do not func-
tion for U6 transcription (Mital et al. 1996; Henry et al.
1998a; Kuhlman et al. 1999), hBRFU efficiently restores
transcription from the U6 promoter in a depleted extract.
Thus, TFIIIB activities in human cells contain TBP, a
factor required very generally for initiation by all three
RNA polymerases, hB, a more specialized factor re-
quired for initiation by RNA polymerase III at all or
many types of RNA polymerase III promoters, and hBRF
or hBRFU, very specialized factors required for initiation
by RNA polymerase III at subclasses of RNA polymerase
III promoters. Figure 9 illustrates the composition TFIIIB
on TATA-less and TATA-containing RNA polymerase
III promoters.
At TATA-less promoters of the tRNA type, the inter-
nal A and B boxes recruit the transcription factor IIIC
(upper panel). This allows the subsequent recruitment of
TFIIIB, which in this case consists of TBP, hBRF, and
hB. TBP and hBRF are tightly associated to each other
in HeLa-cell extracts (Wang and Roeder 1995; Mital et al.
1996), as indicated by the dotted line separating the two
factors. In contrast, hB appears only weakly associated
with the TBP/hBRF complex, if at all, as indicated by the
solid line. Indeed, depletion of extract with anti-hB an-
tibodies did not remove TBP or hBRF (Fig. 4), and in
immunoprecipitations of endogenous hB, we could de-
tect only low levels of TBP and no hBRF (data not
shown). This is similar to the yeast TFIIIB complex,
which consists of strongly associated TBP and BRF, and
much more loosely associated B (Kassavetis et al. 1991;
Huet et al. 1994).
At a TATA-containing promoter such as the human
U6 promoter, the gene external core promoter PSE and
TATA elements recruit SNAPc and TBP, respectively
(lower panel). This presumably allows the subsequent
binding of hBRFU and hB. In this case, the three TFIIIB
components TBP, hBRFU, and hB do not appear to as-
sociate strongly with each other in solution, as indicated
by the solid lines separating the three factors in Figure 9.
Indeed, depletion of extracts with anti-TBP, anti-hBRFU,
or anti-hB antibodies does not, in each case, remove
significant amounts of the two other factors (Figs. 4 and
8; see also Mital et al. 1996; Henry et al. 1998a). Re-
cently, Takada et al. (2000) showed that in Drosophila
cells, the TFIIIB activity contains a hBRF homolog and a
TBP-related factor called TRF1. Together with our re-
sults, these results suggest that there is a wide range of
TFIIIB activities in different species, which contain vari-
ous TBP-like and BRF-like subunits.
Determination of RNA polymerase specificity
at the human snRNA promoters
In mRNA promoters, TFIIB is the factor that directly
recruits RNA polymerase II (Orphanides et al. 1996).
TFIIB also functions on RNA polymerase II snRNA pro-
moters, as evidenced by the observations that depletion
of extracts with anti-TFIIB antibodies debilitates RNA
polymerase II transcription from the U1 promoter but
not RNA polymerase III transcription from the U6 pro-
moter, and that U1 transcription can be restored by ad-
dition of recombinant TFIIB (Kuhlman et al. 1999).
Moreover, TFIIB can be localized to U1 promoter regions
in vivo by chromatin immunoprecipitation (Fig. 5).
Thus, although we have not excluded the possibility that
hBRFU might also be functional at RNA polymerase II
snRNA promoters, it seems likely that on the human
snRNA promoters, RNA polymerase specificity is deter-
mined by the recruitment of TFIIB or hBRFU.
Although the N-terminal half of BRF is very similar to
TFIIB, the functional domain arrangement of the two
factors is different. In TFIIB, the zinc ribbon domain (in-
dicated in blue in Fig. 6) is absolutely required for re-
cruitment of RNA polymerase II and/or TFIIF, and the
core region (indicated in purple in Fig. 6) is required for
association with the TBP/DNA complex (Orphanides et
al. 1996). BRF, like TFIIB, contacts directly the RNA
polymerase, in this case RNA polymerase III (Khoo et al.
1994; Wang and Roeder 1995; Brun et al. 1997; Ferri et al.
2000), but the zinc ribbon domain of BRF is not required
for RNA polymerase III recruitment (Kassavetis et al.
1997, 1998; Hahn and Roberts 2000). Instead, the BRF
zinc ribbon domain, which is essential for both viability
Figure 9. Model of the initiation complexes formed on tRNA-
type and U6-type promoters. The upper panel shows a tRNA-
type promoter with the gene internal A and B box promoter
elements recruiting TFIIIC, which in turn can recruit through
protein–protein contacts the TFIIIB components TBP, hBRF,
and hB. The dotted line separating TBP and hBRF indicates
that these two factors are tightly associated with each other.
The solid line separating hB from the TBP–hBRF complex in-
dicates that hB is only weakly associated with the rest of the
complex. The lower panel shows that for the human U6 gene,
the external PSE and TATA box core promoter elements recruit
SNAPc and the TFIIIB component TBP, respectively. The bind-
ing of these factors probably allows the recruitment of hB and
a TFIIIB component specific for PSE-containing RNA polymer-
ase III promoters, hBRFU. The solid lines separating TBP,
hBRFU, and hB indicate that in this case, the TFIIIB compo-
nents are either not associated or only weakly associated with
each other.
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in yeast and efficient RNA polymerase III transcription
in vitro, plays a role at a later step in open complex
formation (Hahn and Roberts 2000). It will be of great
interest to determine how hBRFU interacts with TBP,
and whether the zinc ribbon domain of hBRFU is re-
quired for recruitment of RNA polymerase III and thus
functionally resembles that of TFIIB, or whether it is
required for open complex formation and thus function-
ally resembles that of BRF.
Materials and methods
Cloning of cDNAs encoding hB and hBRFU
At the time we started isolating a human homolog of yeast B,
the only entry in the database that showed some similarity to
the yeast factor was a mouse EST (GenBank accession number
AA200560) encoding 21 amino acids with strong similarity to
part of the yeast B SANT domain. We used this sequence in-
formation to design primers and then used these primers in
combination with primers hybridizing to the arms of  to screen
various human cDNA libraries. Several rounds of screening,
each time with new primers located near the end of the largest
fragment obtained, resulted in the isolation of a partial cDNA
encoding amino acids 1–1020 of hB. The sequence contained a
stop codon upstream of the first ATG (see GenBank accession
number AF298151), indicating that it encoded the very N ter-
minus of the protein. At this point, a new entry was deposited
in the database (GenBank accession number AB033067).
Nucleotides 822–2243 of the AB033067 sequence were, with a
few exceptions, identical to the last 1422 nucleotides (encoding
amino acids 547–1020) of our sequence, but then the AB033067
sequence extended a further 3.5 kb downstream, the first 1104
nucleotides of which extended the open reading frame another
368 amino acids in the C-terminal direction. The 5 end of the
AB033067 sequence was divergent. We used the AB033067 se-
quence to design primers hybridizing to a region downstream of
the stop codon and to a region within the sequence we had
obtained, and performed PCR reactions from cDNA prepared
from total HeLa-cell RNA. The resulting fragment was cloned
and sequenced, and was nearly identical (except for a few amino
acid changes) to entry AB033067. The sequence of some por-
tions of hB was then further confirmed by the generation, with
the high fidelity Pfu polymerase (Stratagene), of PCR fragments
from cDNA made from total HeLa-cell RNA, followed by se-
quencing of the resulting fragments. A very recent entry in the
database (GenBank accession number AJ238520) matches our
sequence over its entire length almost perfectly. An examina-
tion of genomic sequences in the database indicates that the
entire human B DNA sequence is found on chromosome 5
(GenBank accession number AC008851) and that other entries
in the database (accession numbers AJ238520 and AB033067)
most likely correspond to alternatively spliced products from
the same region. A large region corresponding to the C-terminal
half of the human B sequence can also be found in genomic
DNA from chromosome 2 (GenBank accession number
AC025985).
hBRFU was identified in the database as the human protein
most related to hBRF after TFIIB (GenBank accession number
BAA91975). The sequence information was used to design prim-
ers for PCRs with cDNA made from total HeLa-cell RNA and
the high fidelity Pfu polymerase (Stratagene). The amplified se-
quence (GenBank accession number AF298153) was identical to
the entry in the database except for one silent nucleotide change
and one nucleotide change that changed the codon encoding
cysteine 157 in BAA91975 to a codon encoding tyrosine.
Expression of recombinant proteins in E. coli
hBRF was expressed as an N-terminal glutathione S-transferase
fusion protein from a modified pSBET vector (Schenk et al.
1995). Induction with IPTG was for 1 h at 37°C, and the gluta-
thione S-transferase moiety was cleaved with thrombin. Both
hB and hBRFU were expressed in E. coli as N-terminal His-
tagged and C-terminal FLAG-tagged proteins with the T7 RNA
polymerase expression system (Studier et al. 1990), from modi-
fied pSBET (Schenk et al. 1995) vectors. Briefly, the constructs
were transformed into BL21 cells and single colonies grown in
M9ZB (Studier et al. 1990) at 37°C to an OD600 of 0.8. Induction
was with 0.4 mM IPTG for 4 h at room temperature. The cells
were pelleted and resuspended in 1:10 of the culture volume in
lysis buffer: 10 mM Tris-HCl (pH 8), 250 mM NaCl, 1%Triton
X-100, 50 mM NaH2PO4, 20 mM imidazole, and protease in-
hibitors (1 mM PMSF, 0.5 mM sodium bisulfate, and 0.5 mM
benzamidine). The cells were frozen in liquid nitrogen and
thawed three times, and homogenized with a dounce homog-
enizer on ice. The cell debris was pelleted by centrifugation at
15,000 rpm for 15 min at 4°C in a SS34 rotor (Sorvall). The
supernatant was then incubated with nickel agarose beads (Qia-
gen) overnight at 4°C. The beads were washed three times with
five-bead volume of wash buffer 1 (20 mM Tris-HCl [pH 8], 500
mM NaCl, 20% glycerol, 0.1% Tween 20, 20 mM imidazole,
and protease inhibitors), twice with five-bead volume of wash
buffer 2 (10 mM Tris-HCl [pH 8], 100 mM NaCl, 20% glycerol,
0.01% Nonidet P-40, and protease inhibitors), and the bound
proteins were eluted with wash buffer 2 containing 300 mM
imidazole. The eluate was dialyzed against TBS (20 mM Tris-
HCl [pH 8], 150 mM NaCl, and protease inhibitors) and then
incubated in the same buffer with flag agarose beads (Sigma).
The beads were then washed with TBS containing protease in-
hibitors and eluted with the same buffer containing 200 µg/mL
flag peptide. The eluate was dialyzed against buffer D100: 20%
glycerol, 20 mM HEPES-KOH (pH 7.9), 0.5 mM EDTA, and 100
mM KCl.
Antibodies and immunoblots
The rabbit polyclonal anti-hB antibodies were directed against
peptides corresponding to amino acids 139–153 (peptide hB-2,
CS913) and 392–410 (peptide hB-3, CS843) of hB. The rabbit
polyclonal anti-hBRF antibody that cross-reacts with hBRFU
(rabbit CS1043) was raised against a peptide (R2A) correspond-
ing to amino acids 229–248 of hBRF (Mital et al. 1996). The
anti-TFIIB antibody was from rabbit CS396 (anti-TFIIB-4) (Kuhl-
man et al. 1999).
The protein samples were fractionated on 7.5% SDS–poly-
acrylamide gels and transferred to nitrocellulose membranes.
The membranes were blocked for 1 h at room temperature with
TBS-T (10 mM Tris-HCl [pH 7.5], 150 mM NaCl, and 0.1%
Tween 20) containing 5% BSA and 5% nonfat milk, washed
twice for 10 min in TBS-T, and probed with anti-hB (CS913) or
anti-hBRF/hBRFU (CS1043) antibody at a 1:1000 dilution in
TBS-T containing 5% BSA overnight at 4°C. The membranes
were washed twice for 10 min in TBS-T and probed with the
secondary antibody (sheep anti-rabbit) at a 1:4000 dilution in
TBS-T containing 5% BSA and 2.5% nonfat milk for 1 h at room
temperature. The blots were developed with ECL (Amersham
Life Science) and exposed to film.
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In vitro transcriptions
In vitro transcriptions were performed as described by Kuhlman
et al. (1999) with the following modifications. The U6 transcrip-
tion reactions were performed in a total volume of 40 µL con-
taining 75 ng of the pU6/Hae/RA.2 template, 500 ng of poly
(dG-dC)  poly (dG-dC), and 8 µL of whole-cell extract diluted
1:1, and were complemented with 4 µL of a 10-fold ATP mix (0.5
M ATP, 10 µg/mL phosphocreatine kinase, and 0.5 M creatine
phosphate) and 5–10 ng of recombinant TBP. The VAI transcrip-
tion reactions were performed in a total volume of 20 µL, con-
tained 250 ng of the pSBM13 +VAI template and 8 µL of whole-
cell extract diluted 1:1, and were incubated for 1 h at 37°C. The
Ad2 major late (p119MLP[C2A]) transcription reactions were
performed in a total volume of 30 µL and contained 10 µL of
whole-cell extract diluted 1:1. The U1 (pU1*G-) transcription
reactions were performed in a total volume of 40 µL containing
15 µL of whole-cell extract diluted 1:1. The whole-cell extract
contained 28 mg of protein per mL.
For depletions, 200 µL of extract was mixed with 200 µL of
protein A agarose beads covalently linked to the antibody of
interest overnight at 4°C. The beads were then pelleted by cen-
trifugation, and the depleted extract (diluted 1:1 relative to the
starting extract) was used directly for transcriptions.
Chromatin immunoprecipitations
The formaldehyde cross-linking and immunoprecipitations
were performed as described by P. Farnham and colleagues
(Boyd et al. 1998), except that the NaCl concentration during
immunoprecipitation was raised to 150 mM and the immuno-
precipitations were performed overnight at 4°C. To design the
control primers for the U6 promoter, we used the sequence in a
22-kb contig (GenBank accession number AC009292, contig ex-
tending from 140423 to 162578) that contains the U6 gene we
work with. The control primers (U6C1UP and U6C1L) hybrid-
ized to a sequence located 4 kb upstream of the U6 transcription
start site, and the test U6 primers (U64UP and U62L) bracketed
the core U6 promoter. The PCR reaction consisted of 29 cycles.
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